RadNet, Inc. (RDNT)
73.70
-2.00
(-2.64%)
USD |
NASDAQ |
Sep 03, 10:59
RadNet Cash from Operations (Quarterly) : 94.10M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 94.10M |
| March 31, 2026 | 78.97M |
| December 31, 2025 | 84.16M |
| September 30, 2025 | 52.83M |
| June 30, 2025 | 120.35M |
| March 31, 2025 | 41.48M |
| December 31, 2024 | 42.53M |
| September 30, 2024 | 57.40M |
| June 30, 2024 | 116.00M |
| March 31, 2024 | 17.09M |
| December 31, 2023 | 88.92M |
| September 30, 2023 | 31.25M |
| June 30, 2023 | 68.08M |
| March 31, 2023 | 32.62M |
| December 31, 2022 | 53.65M |
| September 30, 2022 | 27.03M |
| June 30, 2022 | 64.84M |
| March 31, 2022 | 0.901M |
| December 31, 2021 | 49.20M |
| September 30, 2021 | 41.59M |
| June 30, 2021 | 30.62M |
| March 31, 2021 | 28.08M |
| December 31, 2020 | 62.68M |
| September 30, 2020 | 38.88M |
| June 30, 2020 | 90.55M |
| Date | Value |
|---|---|
| March 31, 2020 | 40.91M |
| December 31, 2019 | 21.72M |
| September 30, 2019 | 38.07M |
| June 30, 2019 | 17.64M |
| March 31, 2019 | 26.90M |
| December 31, 2018 | 28.90M |
| September 30, 2018 | 40.91M |
| June 30, 2018 | 22.64M |
| March 31, 2018 | 24.31M |
| December 31, 2017 | 66.64M |
| September 30, 2017 | 25.42M |
| June 30, 2017 | 20.74M |
| March 31, 2017 | 30.90M |
| December 31, 2016 | 35.92M |
| September 30, 2016 | 3.306M |
| June 30, 2016 | 31.46M |
| March 31, 2016 | 20.96M |
| December 31, 2015 | 26.97M |
| September 30, 2015 | 12.11M |
| June 30, 2015 | 10.49M |
| March 31, 2015 | 17.47M |
| December 31, 2014 | 26.96M |
| September 30, 2014 | 14.36M |
| June 30, 2014 | 24.54M |
| March 31, 2014 | -4.86M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Castle Biosciences, Inc. | 15.20M |
| Lumexa Imaging Holdings, Inc. | 32.80M |
| Quest Diagnostics, Inc. | 597.00M |
| Labcorp Holdings, Inc. | 445.50M |
| OPKO Health, Inc. | -43.50M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -63.55M |
| Cash from Financing (Quarterly) | 240.22M |
| Free Cash Flow | 72.37M |
| Free Cash Flow Per Share (Quarterly) | 0.4803 |
| Free Cash Flow to Equity (Quarterly) | -211.86M |
| Free Cash Flow to Firm (Quarterly) | 51.63M |
| Free Cash Flow Yield | 1.27% |